Mylan Receives Final FDA Approvals for Generic Versions of Lamictal Tablets and Lamictal CD

Mylan Inc. today announced that its subsidiaries Mylan Pharmaceuticals Inc. and Genpharm ULC received final approvals from the U.S. FDA for their Abbreviated New Drug Applications for Lamotrigine Tablets.

The details can be read here.